Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Frequency of Covid-19 Infection in Psoriasis Patients Treated With Immunosuppressive and Immunomodulatory Drugs Publisher



Poostiyan N1 ; Shahmoradi Z1 ; Shafiee A2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Skin Diseases and Leishmaniasis Research Center, Department of Dermatology, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Dermatology, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Isfahan Medical School Published:2023


Abstract

Background: Psoriasis patients treated with immunosuppressive and immunomodulatory drugs are at higher risk of infections, also infections can trigger psoriasis. The aim of this study is to investigate the rate of COVID-19 infection with different severity of symptoms in psoriasis patients treated with immunosuppressive and immunomodulatory drugs. Methods: This cross-sectional study was conducted in the summer of 2021 in the Isfahan city. The studied population consisted of psoriasis patients with electronic medical records in Siddiqa Tahereh Medical Center and Al-Zahra Hospital. During phone calls with patients, duration of psoriasis disease, drug used, dose of drug used, history of COVID-19 infection, disease severity (hospitalization, death) and recurrence or exacerbation of psoriasis after COVID-19 infection, were investigated. Findings: 38% of psoriasis patients treated with immunosuppressive and immunomodulatory drugs were infected with COVID-19, 75% were outpatients and 23.5% were hospitalized. In psoriatic patients, 39% of whom treated with Methotrexate (MTX), 40% of whom treated with Adalimumab, and 48% of whom treated with Infliximab mentioned a history of COVID-19 disease. In 22% of patients, the recurrence of psoriasis following COVID-19 was observed. The most history of infection with COVID-19 was reported in psoriasis patients treated with Infliximab, Adalimumab, and MTX, respectively. Conclusion: By suppressing the immune system and reducing its function, immunosuppressive and immunomodulatory drugs can directly increase the chance of contracting COVID-19 and its severity. © 2023 Isfahan University of Medical Sciences(IUMS). All rights reserved.
Related Docs
View other Related Docs
1. The Effect of Methotrexate 1% Topical Gel on Psoriasis, Journal of Isfahan Medical School (2012)
2. Comparative Evaluation of Gracilaria Algae 3% Cream Vs Clobetasol 0.05% Cream in Treatment of Plaque Type Psoriasis: A Randomized, Split-Body, Triple-Blinded Clinical Trial, Dermatologic Therapy (2020)
3. Value of Adding Betamethasone Pulse Therapy to Methotrexate in Treating Patients With Psoriasis, Iranian Journal of Dermatology (2023)
4. Treatment of Localized Psoriasis With a Topical Formufation of Zinc Pyrithione, Acta Dermatovenerologica Alpina, Pannonica et Adriatica (2011)
5. Topical Nicotinamide in Combination With Calcipotriol for the Treatment of Mild to Moderate Psoriasis: A Double-Blinded, Randomized, Comparative Study, Journal of Isfahan Medical School (2015)
6. Antidepressants and the Risk of Psoriasis Induction: A Case-Control Study, Advanced Biomedical Research (2023)
7. Covid-19 and Exacerbation of Dermatological Diseases: A Review of the Available Literature, Dermatologic Therapy (2021)
8. The Efficiency of Florabile Syrup on Intensity of Psoriasis Rashes, Journal of Isfahan Medical School (2021)
Experts (# of related papers)
View all Related Experts
Fariba Iraji (8)
Ali Asilian (3)
Other Related Docs
9. Efficacy of Adding Topical Simvastatin to Topical Calcipotriol on Improvement of Cutaneous Plaque Psoriasis, Journal of Isfahan Medical School (2015)
10. Evaluation of the Efficacy of Topical Caffeine in the Treatment of Psoriasis Vulgaris, Journal of Dermatological Treatment (2005)
11. Cd137: A Member of the Tnfr Family - in Psoriasis Skin Lesions in Comparison With Normal Skin Specimens, Iranian Journal of Pathology (2021)
12. Prevalence of Skin Drug Eruptions in Dermatology Departments of Tehran Hospitals, Journal of Isfahan Medical School (2012)
13. Unexpected Positive Effects of Rituximab and Corticosteroids on Covid-19 in a Patient Suffering From Granulomatosis With Polyangiitis, Advanced Biomedical Research (2021)
14. An Updated Review of the Association of Host Genetic Factors With Susceptibility and Resistance to Covid-19, Journal of Cellular Physiology (2021)
15. Assessment of Psoriasis Incidence in Patients With Active Systemic Lupus Erythematosus, Journal of Isfahan Medical School (2018)
16. Development of Squamous Cell Carcinoma in an Untreated Patient of Psoriasis: A Case Report, Clinical Case Reports (2021)
17. The Prevalence of Covid-19 Infection in Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Neurological Sciences (2021)
18. Real Life Management of Chronic Urticaria: Multicenter and Cross Sectional Study on Patients and Dermatologists in Iran, Dermatologic Therapy (2019)
19. Clinical Signs, Symptoms, and Severity of Covid-19 in Patients With Rheumatic Diseases During the Covid-19 Epidemic, Immunopathologia Persa (2024)
20. Etiology, Clinical Manifestation and Natural Treatments of Psoriasis From the Perspective of Persian Medicine, Traditional and Integrative Medicine (2020)
21. The Association Between Psoriasis and Psoriatic Arthritis With the Risk of Osteoporosis, Osteopenia and Bone Fractures: A Systematic Review and Meta-Analysis, International Journal of Clinical Practice (2021)
22. Efficacy of 15% Azelaic Acid in Psoriasis Vulgaris: A Randomized, Controlled Clinical Trial, Journal of Drugs in Dermatology (2010)
23. Fungal Infections Among Psoriatic Patients: Etiologic Agents, Comorbidities, and Vulnerable Population, Autoimmune Diseases (2021)